2661018
SCDGP · Clinical drug group packinfluenza A virus A/Norway/16606/2021 (H3N2) antigen / influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Norway/16606/2021 (H3N2) antigen / influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product?
influenza A virus A/Norway/16606/2021 (H3N2) antigen / influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product is coded as 2661018 in RxNorm.
What is RxNorm code 2661018?
2661018 is the RxNorm identifier for influenza A virus A/Norway/16606/2021 (H3N2) antigen / influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2661018?
2661018 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2661018?
2661018 maps to UMLS C5844825.